Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes.

Zebrowska, Karolina; Banuelos, Rosa C; Rizzo, Evelyn J; Belk, Kathy W; Schneider, Gary; Degeling, Koen

Zebrowska, Karolina; Banuelos, Rosa C; Rizzo, Evelyn J; Belk, Kathy W; Schneider, Gary; Degeling, Koen.

Afiliación

Zebrowska K; Healthcare Consultancy Group, London, United Kingdom.
Banuelos RC; Healthcare Consultancy Group, New York, NY, United States.
Rizzo EJ; Healthcare Consultancy Group, New York, NY, United States.
Belk KW; Healthcare Consultancy Group, New York, NY, United States.
Schneider G; Healthcare Consultancy Group, New York, NY, United States.
Degeling K; Healthcare Consultancy Group, London, United Kingdom.

Front Pharmacol ; 14: 1249998, 2023.

Article en En | MEDLINE | ID: mdl-38074129

Palabras clave

breast cancer; colorectal cancer; health disparities; inequality; non-small cell lung cancer; oncology; overall survival; progression-free survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google